Stephen Morse, DO
Nephrology · New Orleans, LANPI 1396767034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 153 payments — averaging $37.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Otsuka America Pharmaceutical, Inc.$738
- Vifor Pharma, Inc.$623
- AstraZeneca$606
- Aurinia Pharma U.S., Inc.$516
- Mallinckrodt Hospital Products Inc.$416
- plus $2K from 18 others
Across 22 payments — averaging $2492.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$29K
- Vertex$25K
- Gilead$1K
What the payments were for
- Food & beverage$5,59498%
- Education$912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $1,205 |
| Otsuka America Pharmaceutical, Inc. | 26 | $738 |
| Vifor Pharma, Inc. | 24 | $623 |
| AstraZeneca(2 entities) | 13 | $606 |
| Aurinia Pharma U.S., Inc. | 11 | $516 |
| Mallinckrodt Hospital Products Inc. | 11 | $416 |
| Calliditas Therapeutics US Inc. | 5 | $277 |
| Akebia Therapeutics Inc | 8 | $244 |
| Bayer | 7 | $222 |
| Travere Therapeutics, Inc. | 7 | $146 |
| Nxstage Medical, Inc. | 2 | $122 |
| GSK | 2 | $122 |
| Novartis | 2 | $65 |
| Rockwell Medical, Inc. | 1 | $61 |
| Abbott | 1 | $55 |
| Baxter Healthcare | 1 | $50 |
| Mallinckrodt Enterprises LLC | 2 | $50 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $38 |
| Fresenius USA Marketing, Inc. | 2 | $36 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| EMD Serono, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,685 in reported general payments places this provider in the 75th percentile of 206 nephrology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 16 | $3,171 |
| Nifedipine ErNifedipine | 12 | $171 |
| Carvedilol | 30 | $136 |
| Amlodipine Besylate | 17 | $79 |
| Hydralazine Hcl | 11 | $75 |
| Allopurinol | 12 | $69 |
| Losartan Potassium | 14 | $56 |
| Atorvastatin Calcium | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other nephrology in New Orleans
- Juan Carlos VelezNew Orleans$282K
- Michael TouchyNew Orleans$56K
- Juan MedauraNew Orleans$14K
- Farshid YazdiNew Orleans$14K
- Mihran NaljayanNew Orleans$10K
- Rhea BhargavaNew Orleans$9K
- April FoxNew Orleans$8K
- Myra KleinpeterNew Orleans$7K
- Joshua LowentrittNew Orleans$7K
- Angela ReginelliNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.